Once-daily group | Mean | Confidence limit |
| −95% | +95% |
60-min level mg·L−1 | 19.9 | 16.9 | 23.0 |
6-h level mg·L−1 | 2.7 | 2.0 | 3.5 |
Time when level equaled 1 mg·L−1 h | 10.4 | 7.9 | 12.9 |
K·h−1 | 0.36 | 0.32 | 0.40 |
Half-life h | 1.9 | 1.7 | 2.2 |
Maximum tobramycin level mg·L−1 | 29.1 | 24.5 | 33.7 |
Repeat 60-min level mg·L−1 | 25.6 | 19.5 | 31.7 |
Repeat 6-h level mg·L−1 | 3.3 | 2.2 | 4.5 |
Time when level equaled 1 mg·L−1 h | 9.9 | 6.7 | 13.2 |
K | 0.38 | 0.32 | 0.44 |
Half-life h | 2.0 | 1.5 | 2.4 |
Maximum tobramycin level mg·L−1 | 41.0 | 29.9 | 52.2 |
Twice-daily group | | | |
Peak level mg·L−1 | 10.5 | 8.9 | 12.1 |
Trough level mg·L−1 | 1.3 | 1.1 | 1.6 |
K·h−1 | 0.37 | 0.34 | 0.40 |
Half-life h | 1.9 | 1.7 | 2.0 |
Repeat peak level mg·L−1 | 9.3 | 8.0 | 10.6 |
Repeat trough level mg·L−1 | 1.3 | 0.9 | 1.7 |
K | 0.36 | 0.28 | 0.44 |
Half-life h | 2.0 | 1.5 | 2.5 |